Save
The psychological impact of the follow up procedures
ESGO eAcademy, Eva Greimel, 62418
Risk of secondary cancer after treatment of gynaecological cancer
ESGO eAcademy, David Cibula, 62417
The role of the imaging (CT-RMI-PET/CT) in the follow up
ESGO eAcademy, Nandita de SOUZA, 62416
The role of ultrasound procedures in the follow up
ESGO eAcademy, Manuela LUDOVISI, 62415
Follow up in Gynaecological Malignancies : a challenge
ESGO eAcademy, Paolo Zola, 62414
Beyond the medical aspect: the point of view of the patient
ESGO eAcademy, Paola MOSCONI, 62413
Sexuality and Cancer
ESGO eAcademy, Woet Gianotten & Annette Hasenburg, 58162
Managing Suicide Risk in Cancer Patients
ESGO eAcademy, Maggie Watson & Luigi Grassi, 58153
Classical laparoscopical surgery for hysterectomy, indication and outcome
ESGO eAcademy, Andreas Müller, 63140
Drugable Targets in Ovarian Cancer
ESGO eAcademy, MICHAEL BIRRER, 55524
Early Trials for Targeted Therapy: Specificity and Pitfalls
ESGO eAcademy, Cristiana Sessa, 55523
Panel Discussion
ESGO eAcademy, Session Speakers, 56036
Endpoints in Clinical Trials
ESGO eAcademy, Nicoletta Colombo, 55522
Improvement in Treatment for Ovarian Cancer: a 40 Year Journey
ESGO eAcademy, Stan Kaye, 55520
Critical Review of Clinical Trials - What We Learn from Negative Trials and Where Are We Going?
ESGO eAcademy, Christian Marth, 55519
Panel Discussion
ESGO eAcademy, Session Speakers, 56035
Elderly: the US Perspective
ESGO eAcademy, Bradley J. Monk, 55518
Endpoints and Trial Design in Geriatric Oncology
ESGO eAcademy, Sandro Pignata, 55517
Specificity of Elderly and Chemotherapy
ESGO eAcademy, Gilles Freyer, 55516
How To Calculate Costs of Clinical Trials
ESGO eAcademy, Jacobus Pfisterer, 55515
How To Incorporate Translational Research in Trials - Lessons from Anti-Angiogenic Trials
ESGO eAcademy, MICHAEL BIRRER, 55514
Regulatory Awareness Programme - Regulated Markets
ESGO eAcademy, Andrea Laslop, 65036
Clinical Trial Phases
ESGO eAcademy, Regina Berger, 57604
What is a clinical trial?
ESGO eAcademy, Regina Berger, 57603
Inguinal Lymphadenectomy: Reducing Dehiscence Rate
ESGO eAcademy, Ignacio Zapardiel, 95018
Single Port Extraperitoneal Paraaortic Lymphadenectomy
ESGO eAcademy, Ignacio Zapardiel, 95019
Video Endoscopic Inguinofemoral Lymphadenectomy in Vulvar Cancer
ESGO eAcademy, Alvaro Zapico, 95020
Ultrasound Based Interventions in Gynecologic Oncology
ESGO eAcademy, Michal Zikan, 95021
Modified Gluteal Fold Advancement V-Y Flap for Vulva Reconstruction
ESGO eAcademy, Pierluigi Benedetti Panici, 94962
Pitfalls and Secondary Profit of Daphragmatic Surgery in Advanced Stages of Endometrial and Ovarian Cancer
ESGO eAcademy, Lucie Bresson, 94963
Salvage Surgery for Retroperitoneal Lymph Node Reccurence
ESGO eAcademy, David Cibula, 94964
Splenectomy with Total Omentectomy
ESGO eAcademy, David Cibula, 94965
Standardization of Type C2 Radical Hysterectomy
ESGO eAcademy, David Cibula, 94966
Perineal Pelvic Repair after Posterior Exenteration in an Epistotomy: Metastasis of Cervical Carcinoma
ESGO eAcademy, Santiago Domingo, 94967
RH in LACC Neoadjuvant RT-CHT
ESGO eAcademy, Francesco Fanfani, 94968
Ultrasound Imaging for Staging Supplemented by Corresponding Intraoperative Findings
ESGO eAcademy, Daniela Fischerova, 94969
Surgical Steps in Type B and C Laparoscopic Radical Hysterectomy: Tips and Tricks
ESGO eAcademy, Juan Gilabert-Estelles, 94970
Surgical Vascular Anatomy on the Upper Abdomen
ESGO eAcademy, Luis M. Chiva, 94971
Radical Abdominal Trachelectomy
ESGO eAcademy, Nicolae Ioanid, 94972
Sigmoid Colon Vaginoplasty
ESGO eAcademy, Ates Karakete & Ilker Kahramanoglu, 94973
Paraaortic Recurrence - Laparoscopic Resection: Retroperitoneal Approach
ESGO eAcademy, Tim Mould, 94975
Radical Resection of Intravascular and Intracardiac Tumor
ESGO eAcademy, Pedro T Ramirez, 94976
Robotic Flourescent Sentinel Node Identification in Endometrial Cancer
ESGO eAcademy, Diego Odetto, 94977
Robotic Radical Trachelectomy
ESGO eAcademy, Pedro T Ramirez, 94978
Cytoreductive Surgery & Pathophysiology of Peritoneal Carcinomatosis
ESGO eAcademy, Francesco Raspagliesi, 94979
Upper Abdominal Debulking Procedures
ESGO eAcademy, Cagatay Taskiran, 94980
Laparoscopic Access & Operating in the Retroperitoneal Space - Challenges & Pitfalls
ESGO eAcademy, Martin Widschwendter, 94981
Advanced Ovarian Cancer: Video Presenting Ultrasound Imaging for Staging Supplemented by Corresponding Intraoperative Findings
ESGO eAcademy, Daniela Fischerova, 95029
Ovarian Cancer: Cytoreductive Surgery & Pathophysiology of Peritoneal Carcinomatosis
ESGO eAcademy, Francesco Raspagliesi, 95039
CANCER DURING PREGNANCY: THE OBSTETRICAL POINT OF VIEW
ESGO eAcademy, Kristel Van Calsteren, 39121
IDENTIFICATION OF OVARIAN CANCER PATIENTS AT HIGH RISK OF SURGICAL MORBIDITY AND MORTALITY
ESGO eAcademy, Giovanni Aletti, 39122
MANAGEMENT OF GYNECOLOGIC SOFT TISSUE SARCOMA AFTER COMPLETE RESECTION
ESGO eAcademy, Isabelle Ray-Coquard, 39123
VULVAR CANCER WITH POSITIVE NODES OF THE GROIN - PELVIC LYMPHADENECTOMY, ADJUVANT RADIOTHERAPY OR RADIOCHEMOTHERAPY?
ESGO eAcademy, Sven Mahner, 39124
ISOLATED TUMOUR CELLS AND MICROMETASTASES: HOW TO DEAL WITH IT?
ESGO eAcademy, Nadeem Abu Rustum, 39125
PITFALLS IN SENTINEL NODE DETECTION IN VULVAR CANCER: AN IN DEPTH ANALYSIS OF FALSE NEGATIVE CASES
ESGO eAcademy, Maaike Oonk, 39126
QUALITY OF LIFE AND SURVIVAL AFTER SN BIOPSY. RESULTS OF THE SENTICOL II, RANDOMIZED TRIAL
ESGO eAcademy, Patrice Mathevet, 39127
ENDOMETRIAL CANCER: PREOPERATIVE ULTRASOUND ASSESSMENT TO TAILOR SURGERY
ESGO eAcademy, Elisabeth Epstein, 39118
NEW IMAGING TECHNOLOGY IN OVARIAN CANCER
ESGO eAcademy, Ate G.J. van der Zee, 39119
ULTRASOUND VERSUS MRI IN CERVICAL CANCER STAGING AND INDIVIDUAL TREATMENT PLANNING
ESGO eAcademy, Daniela Fischerova, 39120
IMAGING PRE-INVASIVE TUBAL LESIONS IN HIGH RISK POPULATIONS
ESGO eAcademy, Jessica McAlpine, 39112
TUBAL PATHOLOGY IN BRCA 1 AND 2 MUTATION CARRIERS
ESGO eAcademy, Ronny Drapkin, 39114
CONTROVERSIES IN ADJUVANT THERAPY
ESGO eAcademy, Wui-Jin Koh, 39115
CONTROVERSIES IN THE MANAGEMENT OF ADVANCED CASES IN VULVAR CANCER
ESGO eAcademy, Lukas Rob, 39116
CURRENT STATUS OF SENTINEL LYMPH NODE MAPPING IN VULVAR CANCER
ESGO eAcademy, Ate G.J. van der Zee, 39117
IMPLICATIONS FOR FUTURE RESEARCH
ESGO eAcademy, Ignace Vergote, 39341
REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - US VIEW
ESGO eAcademy, Sean C. Dowdy, 39339
REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - EUROPEAN VIEW
ESGO eAcademy, Nicoletta Colombo, 39338
COMPLICATIONS AND MORTALITY ASSOCIATED WITH PRIMARY OPTIMAL CYTOREDUCTION
ESGO eAcademy, Angelo Maggioni, 39109
NEOADJUVANT CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER
ESGO eAcademy, Ignace Vergote, 39110
PREOPERATIVE AND LAPAROSCOPIC EVALUATION FOR OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER
ESGO eAcademy, Giovanni Scambia, 39111
GUIDELINES AND LEVEL OF EVIDENCE FROM THE TRIALS
ESGO eAcademy, John A Green, 39105
Treatment-Surgery-Lymph Nodes- Radiotherapy- Chemotherapy- Individualization- Recurrence
ESGO eAcademy, Paolo Zola, 39106
WHAT IS ENDOMETRIAL CANCER - PATHOLOGY, MOLECULAR CHARACTERISATION ETC, EPIDEMIOLOGY
ESGO eAcademy, Glenn McCluggage, 39108
IS THE THERAPY-FREE INTERVAL OF 6 MONTHS STILL A USEFUL MODEL FOR GUIDING 2NDLINE OR HIGHER THERAPIES IN OVARIAN CANCER?
ESGO eAcademy, Daniel U. Reimer, 39100
TREATMENT CONSIDERATIONS IN CERVICAL CANCER WITH PELVIC RECURRENCE AFTER ADJUVANT OR PRIMARY RADIOCHEMOTHERAPY
ESGO eAcademy, Stefano Greggi, 39101
TREATMENT CONSIDERATIONS IN PATIENTS WITH RECURRENT CARCINOMATOSIS AFTER SEVERAL LINES OF CHEMOTHERAPY AND SUBILEUS/ILEUS
ESGO eAcademy, Philip Harter, 39102
TREATMENT CONSIDERATIONS IN VULVA CARCINOMA WITH LOCO-REGIONAL RECURRENCE
ESGO eAcademy, Ate G.J. van der Zee, 39103
PROGRESS IN RISK PREDICTION, DIAGNOSIS AND SCREENING FOR OVARIAN CANCER
ESGO eAcademy, Ian Jacobs, 39099
Vaginal Trachelectomy + Laparoscopic LND
ESGO eAcademy, Achim Schneider, 39134
Surgical Staging of Cervical Carcinoma and Extraperitoneal LND
ESGO eAcademy, Eric Leblanc, 39135
ROBOTIC SURGERY FOR THE MANAGEMENT OF CERVICAL CANCER
ESGO eAcademy, Angelo Maggioni, 39136
Vulva Cancer: VFR and Recostruction with Flaps
ESGO eAcademy, Nadja Dornhöfer, 39138
SLN in Vulvar Cancer
ESGO eAcademy, Ate G.J. van der Zee, 39139
PALLIATIVE AND END OF LIFE CARE IN GYNECOLOGICAL CANCER - GOING BEYOND THE PHYSICAL
ESGO eAcademy, Mari Lloyd-Williams, 39097
PALLIATIVE CARE - END OF LIFE CARE IN GYNECOLOGICAL CANCER : ASPECTS OF CLINICAL PRACTICE
ESGO eAcademy, Johan Menten, 39098
Cancer: A Family Affair
ESGO eAcademy, Lea Baider, 48149
Anxiety and Adjustment Disorders in Cancer Patients
ESGO eAcademy, Katalin Muszbek, 48150
Loss, Grief and Bereavement
ESGO eAcademy, David Kissane, 48151
Palliative Care for the Psycho-Oncologist
ESGO eAcademy, William Breitbart, 48152
Ethical Implications of Psycho-Oncology
ESGO eAcademy, Antonella Surbone, 48153
Psychosocial Interventions: Evidence and Methods for Supporting Cancer Patients
ESGO eAcademy, Maggie Watson & Barry Bultz, 48154
Psychosocial Assessment in Cancer Patients
ESGO eAcademy, Uwe Koch & Anja Mehnert, 48155
Communication and Interpersonal Skills in Cancer Care
ESGO eAcademy, Walter F. Baile, 48156
Distress Management in Cancer
ESGO eAcademy, Jimmie C. Holland, 48157
Depression and Depressive Disorders in Cancer Patients
ESGO eAcademy, Luigi Grassi & Yosuke Uchitomi, 48158
Guideliness and Evidence from the Trials about Follow up
ESGO eAcademy, Elisa Piovano, 45901
PERSONALIZED SURGICAL CARE FOR CERVICAL CANCER
ESGO eAcademy, Rene H.M. Verheijen, 39091
SENTINEL NODE CONCEPT AND RELEVANCE OF DETECTION OF MICROMETASTASES
ESGO eAcademy, David Cibula, 39092
(NEO-) ADJUVANT CHEMOTHERAPY AND CERVICAL CANCER
ESGO eAcademy, Roberto Angioli, 39093
NO HEALTH WITHOUT MENTAL HEALTH: THE IMPORTANCE OF PSYCHOSOCIAL CARE IN GYNAECOLOGICAL CANCER
ESGO eAcademy, Maggie Watson, 39083

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings